Defunct Company
Total Trials
14
As Lead Sponsor
6
As Collaborator
8
Total Enrollment
946
NCT00429533
Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 1996
Completion: Feb 29, 2004
NCT02090725
Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)
Role: Collaborator
Start: Feb 29, 2004
Completion: Nov 28, 2018
NCT00417690
High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease
Start: Jan 31, 2007
Completion: Oct 31, 2008
NCT00495521
High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children
Start: Jun 30, 2007
NCT01511978
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Start: Jan 31, 2012
Completion: Jul 31, 2015